使宿

Jack Hutchinson1, Yali Lu2, Lara Grew3

  • 1Purification Process Sciences, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; Analytical Sciences, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

PubMed
概括

这项研究开发了一种有效的策略,用于在生物治疗生产过程中减少宿主细胞蛋白 (HCP). 使用多模式染色学 (MMC),研究人员实现了显著的HCP清除,提高了整体产品的纯度.